22 attorneys general say pulling abortion pill from U.S. would have ‘devastating consequences’

22 attorneys general say pulling abortion pill from U.S. would have ‘devastating consequences’


The attorneys general from 21 states and Washington, D.C., on Friday argued that the attempt to pull the abortion pill from the U.S. market would have “devastating consequences” for women.

The filing in federal district court in Texas comes in response to a lawsuit by anti-abortion physicians who have asked that court to overturn the Food and Drug Administration’s two-decade-old approval of mifepristone.

The attorneys general argued that overturning the FDA approval would make the pill largely unavailable, forcing women to either undergo a more invasive surgical procedure or forgo abortion altogether.

Surgical portion is also more costly and difficult to obtain, they argued, which would disproportionately impact women who are lower-income, underserved or live in rural communities where there might not be access to a clinic.

“This would have devastating consequences,” the attorneys general told Judge Matthew Kacsmaryk, who is presiding over the case in the U.S. district court in Northern Texas.

The abortion rights group NARAL Pro-Choice America, in an analysis published Friday, said 40 million women would lose access to the abortion pill if the court overturns the FDA’s approval.

Used in combination with misoprostol, mifepristone is the most common method to terminate a pregnancy in the U.S., accounting for about half of all abortions.

Kacsmaryk on Thursday extended a key deadline in the case. He ordered one of the abortion pill makers, Danco Laboratories, to lay out its opposition to the lawsuit. The anti-abortion physicians who brought the case then have until Feb. 24 to respond.

“Forcing FDA to withdraw a longstanding approval would seismically disrupt the agency’s governing authority as to whether drugs are safe and effective, and would cause Danco direct and immediate harm by shuttering its business,” the attorneys for Danco Laboratories told the court on Friday.

Mifepristone has become the central focus in the battle over abortion access since the Supreme Court overturned Roe v. Wade last June.

New York led the coalition of state attorneys general and Washington, D.C. in arguing to keep mifepristone on the market. The other states included California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, North Carolina, Oregon, Pennsylvania, Rhode Island, Washington and Wisconsin.

The FDA last month changed its regulations to allow certified retail pharmacies to dispense mifepristone. CVS and Walgreens, the nation’s two largest drugstore chains, have said they are getting certified to dispense the prescription medication in states where it’s legal to do so.

Republican attorneys general warned the companies against distributing the pill by mail in their states, indicating that they would take legal action.

There are also lawsuits seeking to overturn state restrictions on mifepristone, arguing that they conflict with FDA regulations. GenBioPro, the other abortion pill manufacturer, is suing to overturn West Virginia’s ban. A physician in North Carolina is challenging that state’s restrictions.



Source

Startup Teal Health wins FDA approval for at-home test for cervical cancer screening
Health

Startup Teal Health wins FDA approval for at-home test for cervical cancer screening

The Food and Drug Administration on Friday approved the first-ever at-home test for cervical cancer screening, developed by San Francisco-based startup Teal Health. The company began developing the prototype for its Teal Wand just over five years ago. The concept was to make cervical cancer screening more accessible via telehealth and a test that could […]

Read More
These 6 portfolio names pledged big U.S. investments since Trump took office again
Health

These 6 portfolio names pledged big U.S. investments since Trump took office again

Many of the biggest U.S. companies have pledged to invest trillions of dollars in the United States since President Donald Trump started his second term — including six names in our portfolio. These moves are aimed at aligning companies with the president’s vision for a new global trade order designed to bring manufacturing jobs back […]

Read More
UnitedHealthcare sued by shareholders over reaction to CEO’s killing
Health

UnitedHealthcare sued by shareholders over reaction to CEO’s killing

Brian Thompson, CEO of UnitedHealthcare. Courtesy: UnitedHealth Group A group of investors sued UnitedHealthcare Group on Wednesday, accusing the company of misleading them after the killing of its CEO, Brian Thompson. The class action lawsuit — filed in the Southern District of New York — accuses the health insurance company of not initially adjusting their 2025 […]

Read More